Caricamento...
RCHOP和RCDOP方案治疗弥漫大B细胞淋巴瘤后间质性肺炎发生率的研究
OBJECTIVE: To identify the risk factors and clinical features associated with the interstitial pneumonia in diffuse large B-cell lymphoma（DLBCL）patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone（RCHOP）or rituximab, cyclophosphamide, liposomal doxorubicin, vinc...
Salvato in:
| Pubblicato in: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Editorial office of Chinese Journal of Hematology
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342673/ https://ncbi.nlm.nih.gov/pubmed/32023732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.008 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|